Alzheimer's Fast Track 2021

Alzheimer's Fast Track 2021

December 1-3, 2021

Section Page Hero Image


The Alzheimer’s Fast Track workshop is designed for graduate students, postdoctoral fellows, or other early-career scientists focused on Alzheimer’s disease research to participate in an immersive learning experience that accelerates their knowledge, expertise, and visibility in this exciting field.

Download the program book here.

AFT 2021 Group pics


“Dedicated time with the mentors to help guide the project was a super cool aspect of the conference.”

“Surpassed my expectations – the level of interactiveness – truly immersive experience even though virtual.”

“I felt like I actually got to meet leaders in the field in a more meaningful way.”

Registration for the event is now closed.



Sharyn Rossi, PhD


Frank LaFerla, PhD


Cynthia Lemere, PhD


Harry Steinbusch, PhD

This year’s Fast Track will be virtual but will continue to provide an interactive experience that supports the development and education of young researchers who are working in or entering the field of Alzheimer’s disease research.

The Immersive Workshop experience includes:

  • Pre-recorded on-demand talks
  • Live topic discussions
  • Breakout sessions with the speakers
  • Feedback from a communications coach
  • Final group presentation of a mock grant proposal

The Workshop is limited to 60 attendees and will be filled on a first-come-first-served basis. You will be asked to provide a biosketch, abstract, and headshot during registration. Once the Immersive Workshop reaches capacity, you will be encouraged to register for the Virtual Webinar portion of the event.

The Virtual Webinar includes:

  • Access to On-Demand Talks
  • Interactive Platform Features
  • 2 Live Keynote Presentations
  • Live Discussions on 6 Hot Topics in AD

This year, our six topics include:

Racial and Sex Disparities


  • Sid O’Bryant, PhD — The University of North Texas
  • Rachel Buckley, PhD — Massachusetts General Hospital
  • Michelle Mielke, PhD — Mayo Clinic, MN

Lifestyle Interventions


  • Francesca Mangialasche, PhD — Karolinska Institute
  • Laurie Cox, PhD — Brigham and Women’s Hospital
  • Julie Andersen, PhD — Buck Institute

Neuroglial Contributions


  • Jorge Palop, PhD — Gladstone Institutes
  • Elizabeth Head, PhD — University of California, Irvine
  • Ksenia Kastanenka, PhD — Massachusetts General Hospital
  • Arthur Butt, PhD — University of Portsmouth

Neurological effects of COVID 19


  • Patrick Kehoe, PhD — University of Bristol
  • Malu Tansey, PhD — University of Florida

Model Systems


  • Jerome Mertens, PhD — Salk Institute/University of Innsbruck
  • Joanna Jankowsky, PhD — Baylor College of Medicine
  • Mathew Blurton-Jones, PhD — University of California, Irvine

Therapeutic Strategies


  • Giacomo Koch, PhD — Fondazione Santa Lucia
  • Kevin Chen, MD — University of Michigan
  • Dave Holtzman, MD — Washington University of St. Louis